Ascentage Pharma Group International (AAPG) Current Leases (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Current Leases for 3 consecutive years, with $1.0 million the latest figure, recorded in Q4 2025.

• Quarterly Current Leases fell 21.86% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 21.86% YoY) and the FY2025 annual result came in at $1.0 million, down 19.49% from the prior year.
• Current Leases fell to $1.0 million in Q4 2025 per AAPG's latest filing, from $1.3 million in the prior quarter.
• Over the last five years, Current Leases for AAPG reached as high as $1.4 million in Q4 2023 and fell as low as $1.0 million in Q4 2025.
• A 3-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases fell 3.03% — and 2025, when it dropped 21.86%.
• Year by year, Current Leases stood at $1.4 million in 2023, then fell by 3.03% to $1.3 million in 2024, then slipped by 21.86% to $1.0 million in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $1.0 million, $1.3 million, and $1.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.